We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Neural Network Recognizes Breast Cancer on Histological Samples With 100% Accuracy

By LabMedica International staff writers
Posted on 02 Feb 2024
Print article
Image: The “attentive” neural network recognizes breast cancer with 99.6% accuracy (Photo courtesy of RUDN University)
Image: The “attentive” neural network recognizes breast cancer with 99.6% accuracy (Photo courtesy of RUDN University)

The likelihood of a favorable outcome for a breast cancer patient is greatly influenced by the stage at which the cancer is diagnosed. Histological examination is the benchmark for diagnosis, but its reliability can be affected by subjective interpretations and the quality of the tissue sample. Inaccuracies in these examinations can lead to incorrect diagnoses. Now, a team of mathematicians has developed a machine learning model that significantly enhances the accuracy of identifying cancer in histological images. The highlight of this model is the incorporation of an additional module that boosts the neural network's "attention" capability, enabling it to achieve near-perfect accuracy.

The mathematicians at RUDN University (Moscow, Russia) conducted tests on several convolutional neural networks and supplemented them with two convolutional attention modules. These modules are crucial for detecting objects within images. The model underwent training and testing using the BreakHis dataset, which comprises nearly 10,000 histological images at various scales, sourced from 82 patients. The most impressive performance came from a model that combined the DenseNet211 convolutional network with the attention modules, achieving a remarkable accuracy rate of 99.6%. The research team noted that the detection of cancerous formations is affected by image scale. This is because images differ in quality at various zoom levels, and cancerous formations appear differently. Therefore, during practical application, selecting the appropriate scale for image analysis must be a critical consideration.

“Computer classification of histological images will reduce the burden on doctors and increase the accuracy of tests. Such technologies will improve the treatment and diagnosis of breast cancer. Deep learning methods have shown promising results in medical image analysis problems in recent years,” said Ammar Muthanna, Ph.D., Director of the Scientific Center for Modeling Wireless 5G Networks at RUDN University. “The attention modules in the model improved feature extraction and the overall performance of the model. With their help, the model focused on significant areas of the image and highlighted the necessary information. It shows the importance of attention mechanisms in the analysis of medical images.”

Related Links:
RUDN University

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
HbA1c Test
HbA1c Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.